(Q51589248)

7 April 2018

title

Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients (English)

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

27 May 2024

0 references

1 reference

1 reference

T. Kayashima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

K. Yamaguchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

Y. Konno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

H. Nanimatsu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

S. Aragaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

M. Shichiri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7587919

27 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7587919

27 May 2024

publication date

1 May 1995

1 reference

7 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016882279501066M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

https://api.elsevier.com/content/article/PII:016882279501066M?httpAccept=text/plain

27 May 2024

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Diabetes Research and Clinical Practice

27 May 2024

published in

1 reference

7 April 2018

volume

28

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

119-125

1 reference

7 April 2018

The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Clinical experience with a new device that will simplify insulin injections

27 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

27 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects

27 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary-failure to sulfonylureas. A five year follow-up study

27 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

The effect of short-term basal insulin supplementation with human ultralente insulin on diurnal glycemic control in NIDDM patients

27 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.

27 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

27 May 2024

Glucose toxicity

12

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

27 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

27 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.

27 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

27 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics

27 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion

27 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Pathogenesis of NIDDM. A balanced overview

27 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment

27 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus

27 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

Trial of placebo in long-term chlorpropamide-treated diabetics

27 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0168-8227(95)01066-M

27 May 2024

Identifiers

1 reference

7 April 2018

1 reference

7 April 2018